#biomarkers

Researchers identify miR-149-5p as a key driver of immune escape in bronchial lesions that can progress to squamous cell lung cancer.

A multi-omics approach achieves 92% accuracy in forecasting organ failure and mortality in trauma patients, days before symptoms appear.

Researchers identify blood-based biomarkers that forecast trauma patient outcomes days before clinical signs appear, transforming critical care.